Ontology type: schema:ScholarlyArticle
2014-04-18
AUTHORSNoriyuki Akutsu, Shigeru Sasaki, Hideyasu Takagi, Masayo Motoya, Masahiro Shitani, Mai Igarashi, Daisuke Hirayama, Hideki Wakasugi, Hiroyuki Yamamoto, Hiroyuki Kaneto, Kazuhiko Yonezawa, Atsushi Yawata, Takeya Adachi, Yasuo Hamamoto, Yasuhisa Shinomura
ABSTRACTBackgroundSorafenib is an agent that inhibits vascular endothelial growth factor and is associated with onset or worsening of hypertension in some patients. We conducted a retrospective analysis of whether the development of hypertension during sorafenib treatment of advanced hepatocellular carcinoma could be a predictor of anti-cancer efficacy.MethodsThe study included 38 patients with advanced hepatocellular carcinoma who had received sorafenib for at least 1 month between January 2010 and December 2012. A retrospective analysis of the efficacy of sorafenib was conducted by dividing the patients into two groups—a hypertension group, presenting with grade 2 or higher hypertension according to the Common Terminology Criteria for Adverse Events (CTCTE) version 4.0; and a non-hypertension group, which included all other patients. This study evaluated the occurrence of hypertension within 2 weeks of initiation of therapy in order to avoid any treatment duration bias. Images were evaluated using the modified Response Evaluation Criteria in Solid Tumors. The response rate, time to progression, and overall survival were assessed.ResultsTwenty-two patients (58 %) developed grade 2 or higher hypertension within 2 weeks of initiation of therapy. The response rate was significantly higher in the hypertension group. Median time to progression was 153 days in the hypertension group versus 50.5 days in the non-hypertension group, which was significantly longer in the hypertension group. Moreover, median overall survival was 1,329 days in the hypertension group versus 302 days in the non-hypertension group, which was significantly longer in the hypertension group.ConclusionsHypertension within 2 weeks of initiation of therapy may be a predictor of the anti-cancer efficacy of sorafenib when used for the treatment of advanced hepatocellular carcinoma. More... »
PAGES105-110
http://scigraph.springernature.com/pub.10.1007/s10147-014-0691-5
DOIhttp://dx.doi.org/10.1007/s10147-014-0691-5
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1051226834
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/24744262
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Oncology and Carcinogenesis",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Aged, 80 and over",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Antineoplastic Agents",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Carcinoma, Hepatocellular",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Disease Progression",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Female",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Hypertension",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Liver Neoplasms",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Male",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Middle Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Niacinamide",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Phenylurea Compounds",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Retrospective Studies",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Sorafenib",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Department of Gastroenterology, Rheumatology, and Clinical Immunology, Sapporo Medical University, S-1, W-16, Chuo-ku, 060-8543, Sapporo, Japan",
"id": "http://www.grid.ac/institutes/grid.263171.0",
"name": [
"Department of Gastroenterology, Rheumatology, and Clinical Immunology, Sapporo Medical University, S-1, W-16, Chuo-ku, 060-8543, Sapporo, Japan"
],
"type": "Organization"
},
"familyName": "Akutsu",
"givenName": "Noriyuki",
"id": "sg:person.0653757221.97",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0653757221.97"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Gastroenterology, Rheumatology, and Clinical Immunology, Sapporo Medical University, S-1, W-16, Chuo-ku, 060-8543, Sapporo, Japan",
"id": "http://www.grid.ac/institutes/grid.263171.0",
"name": [
"Department of Gastroenterology, Rheumatology, and Clinical Immunology, Sapporo Medical University, S-1, W-16, Chuo-ku, 060-8543, Sapporo, Japan"
],
"type": "Organization"
},
"familyName": "Sasaki",
"givenName": "Shigeru",
"id": "sg:person.01142041007.18",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01142041007.18"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Gastroenterology, Rheumatology, and Clinical Immunology, Sapporo Medical University, S-1, W-16, Chuo-ku, 060-8543, Sapporo, Japan",
"id": "http://www.grid.ac/institutes/grid.263171.0",
"name": [
"Department of Gastroenterology, Rheumatology, and Clinical Immunology, Sapporo Medical University, S-1, W-16, Chuo-ku, 060-8543, Sapporo, Japan"
],
"type": "Organization"
},
"familyName": "Takagi",
"givenName": "Hideyasu",
"id": "sg:person.01245657731.20",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01245657731.20"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Gastroenterology, Rheumatology, and Clinical Immunology, Sapporo Medical University, S-1, W-16, Chuo-ku, 060-8543, Sapporo, Japan",
"id": "http://www.grid.ac/institutes/grid.263171.0",
"name": [
"Department of Gastroenterology, Rheumatology, and Clinical Immunology, Sapporo Medical University, S-1, W-16, Chuo-ku, 060-8543, Sapporo, Japan"
],
"type": "Organization"
},
"familyName": "Motoya",
"givenName": "Masayo",
"id": "sg:person.013442556215.57",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013442556215.57"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Gastroenterology, Rheumatology, and Clinical Immunology, Sapporo Medical University, S-1, W-16, Chuo-ku, 060-8543, Sapporo, Japan",
"id": "http://www.grid.ac/institutes/grid.263171.0",
"name": [
"Department of Gastroenterology, Rheumatology, and Clinical Immunology, Sapporo Medical University, S-1, W-16, Chuo-ku, 060-8543, Sapporo, Japan"
],
"type": "Organization"
},
"familyName": "Shitani",
"givenName": "Masahiro",
"id": "sg:person.01072134024.03",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01072134024.03"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Gastroenterology, Rheumatology, and Clinical Immunology, Sapporo Medical University, S-1, W-16, Chuo-ku, 060-8543, Sapporo, Japan",
"id": "http://www.grid.ac/institutes/grid.263171.0",
"name": [
"Department of Gastroenterology, Rheumatology, and Clinical Immunology, Sapporo Medical University, S-1, W-16, Chuo-ku, 060-8543, Sapporo, Japan"
],
"type": "Organization"
},
"familyName": "Igarashi",
"givenName": "Mai",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Gastroenterology, Rheumatology, and Clinical Immunology, Sapporo Medical University, S-1, W-16, Chuo-ku, 060-8543, Sapporo, Japan",
"id": "http://www.grid.ac/institutes/grid.263171.0",
"name": [
"Department of Gastroenterology, Rheumatology, and Clinical Immunology, Sapporo Medical University, S-1, W-16, Chuo-ku, 060-8543, Sapporo, Japan"
],
"type": "Organization"
},
"familyName": "Hirayama",
"givenName": "Daisuke",
"id": "sg:person.01266033320.24",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01266033320.24"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Gastroenterology, Rheumatology, and Clinical Immunology, Sapporo Medical University, S-1, W-16, Chuo-ku, 060-8543, Sapporo, Japan",
"id": "http://www.grid.ac/institutes/grid.263171.0",
"name": [
"Department of Gastroenterology, Rheumatology, and Clinical Immunology, Sapporo Medical University, S-1, W-16, Chuo-ku, 060-8543, Sapporo, Japan"
],
"type": "Organization"
},
"familyName": "Wakasugi",
"givenName": "Hideki",
"id": "sg:person.0725602615.99",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0725602615.99"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Gastroenterology, Rheumatology, and Clinical Immunology, Sapporo Medical University, S-1, W-16, Chuo-ku, 060-8543, Sapporo, Japan",
"id": "http://www.grid.ac/institutes/grid.263171.0",
"name": [
"Department of Gastroenterology, Rheumatology, and Clinical Immunology, Sapporo Medical University, S-1, W-16, Chuo-ku, 060-8543, Sapporo, Japan"
],
"type": "Organization"
},
"familyName": "Yamamoto",
"givenName": "Hiroyuki",
"id": "sg:person.0635431612.98",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0635431612.98"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Gastroenterology, Muroran City General Hospital, 3-8-1 Yamatecho, 051-8512, Muroran, Hokkaido, Japan",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Department of Gastroenterology, Muroran City General Hospital, 3-8-1 Yamatecho, 051-8512, Muroran, Hokkaido, Japan"
],
"type": "Organization"
},
"familyName": "Kaneto",
"givenName": "Hiroyuki",
"id": "sg:person.01325100071.24",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01325100071.24"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Gastroenterology, Kushiro City General Hospital, 1-12 Shunkodai, 085-0822, Kushiro, Hokkaido, Japan",
"id": "http://www.grid.ac/institutes/grid.415580.d",
"name": [
"Department of Gastroenterology, Kushiro City General Hospital, 1-12 Shunkodai, 085-0822, Kushiro, Hokkaido, Japan"
],
"type": "Organization"
},
"familyName": "Yonezawa",
"givenName": "Kazuhiko",
"id": "sg:person.0611354215.09",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0611354215.09"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Gastroenterology, Hakodate Goryoukaku Hospital, 38-3 Goryoukaku, 040-8611, Hakodate, Hokkaido, Japan",
"id": "http://www.grid.ac/institutes/grid.513242.3",
"name": [
"Department of Gastroenterology, Hakodate Goryoukaku Hospital, 38-3 Goryoukaku, 040-8611, Hakodate, Hokkaido, Japan"
],
"type": "Organization"
},
"familyName": "Yawata",
"givenName": "Atsushi",
"id": "sg:person.01003370772.98",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01003370772.98"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Gastroenterology, Otaru City General Hospital, 1-2-1 Wakamatsu, 047-8550, Otaru, Hokkaido, Japan",
"id": "http://www.grid.ac/institutes/grid.417343.6",
"name": [
"Department of Gastroenterology, Otaru City General Hospital, 1-2-1 Wakamatsu, 047-8550, Otaru, Hokkaido, Japan"
],
"type": "Organization"
},
"familyName": "Adachi",
"givenName": "Takeya",
"id": "sg:person.01214634707.82",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01214634707.82"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Division of Gastroenterology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, 160-8582, Shinjuku, Tokyo, Japan",
"id": "http://www.grid.ac/institutes/grid.26091.3c",
"name": [
"Division of Gastroenterology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, 160-8582, Shinjuku, Tokyo, Japan"
],
"type": "Organization"
},
"familyName": "Hamamoto",
"givenName": "Yasuo",
"id": "sg:person.01065374573.59",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01065374573.59"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Gastroenterology, Rheumatology, and Clinical Immunology, Sapporo Medical University, S-1, W-16, Chuo-ku, 060-8543, Sapporo, Japan",
"id": "http://www.grid.ac/institutes/grid.263171.0",
"name": [
"Department of Gastroenterology, Rheumatology, and Clinical Immunology, Sapporo Medical University, S-1, W-16, Chuo-ku, 060-8543, Sapporo, Japan"
],
"type": "Organization"
},
"familyName": "Shinomura",
"givenName": "Yasuhisa",
"id": "sg:person.0643127340.79",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0643127340.79"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1007/s12032-012-0327-4",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1021614388",
"https://doi.org/10.1007/s12032-012-0327-4"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/jhh.2013.30",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1012376760",
"https://doi.org/10.1038/jhh.2013.30"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/1471-2407-12-107",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1002590166",
"https://doi.org/10.1186/1471-2407-12-107"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/bjc.2012.152",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1017504688",
"https://doi.org/10.1038/bjc.2012.152"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/bjc.2011.2",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1053652173",
"https://doi.org/10.1038/bjc.2011.2"
],
"type": "CreativeWork"
}
],
"datePublished": "2014-04-18",
"datePublishedReg": "2014-04-18",
"description": "BackgroundSorafenib is an agent that inhibits vascular endothelial growth factor and is associated with onset or worsening of hypertension in some patients. We conducted a retrospective analysis of whether the development of hypertension during sorafenib treatment of advanced hepatocellular carcinoma could be a predictor of anti-cancer efficacy.MethodsThe study included 38 patients with advanced hepatocellular carcinoma who had received sorafenib for at least 1\u00a0month between January 2010 and December 2012. A retrospective analysis of the efficacy of sorafenib was conducted by dividing the patients into two groups\u2014a hypertension group, presenting with grade 2 or higher hypertension according to the Common Terminology Criteria for Adverse Events (CTCTE) version 4.0; and a non-hypertension group, which included all other patients. This study evaluated the occurrence of hypertension within 2 weeks of initiation of therapy in order to avoid any treatment duration bias. Images were evaluated using the modified Response Evaluation Criteria in Solid Tumors. The response rate, time to progression, and overall survival were assessed.ResultsTwenty-two patients (58\u00a0%) developed grade 2 or higher hypertension within 2 weeks of initiation of therapy. The response rate was significantly higher in the hypertension group. Median time to progression was 153\u00a0days in the hypertension group versus 50.5\u00a0days in the non-hypertension group, which was significantly longer in the hypertension group. Moreover, median overall survival was 1,329\u00a0days in the hypertension group versus 302\u00a0days in the non-hypertension group, which was significantly longer in the hypertension group.ConclusionsHypertension within 2 weeks of initiation of therapy may be a predictor of the anti-cancer efficacy of sorafenib when used for the treatment of advanced hepatocellular carcinoma.",
"genre": "article",
"id": "sg:pub.10.1007/s10147-014-0691-5",
"isAccessibleForFree": false,
"isPartOf": [
{
"id": "sg:journal.1312225",
"issn": [
"1341-9625",
"1437-7772"
],
"name": "International Journal of Clinical Oncology",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "1",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "20"
}
],
"keywords": [
"advanced hepatocellular carcinoma",
"weeks of initiation",
"non-hypertension group",
"hypertension group",
"development of hypertension",
"hepatocellular carcinoma",
"anti-cancer efficacy",
"overall survival",
"higher hypertension",
"retrospective analysis",
"grade 2",
"response rate",
"Adverse Events version 4.0",
"worsening of hypertension",
"Common Terminology Criteria",
"median overall survival",
"Response Evaluation Criteria",
"ResultsTwenty-two patients",
"efficacy of sorafenib",
"occurrence of hypertension",
"predictors of efficacy",
"vascular endothelial growth factor",
"endothelial growth factor",
"Terminology Criteria",
"median time",
"sorafenib treatment",
"hypertension",
"MethodsThe study",
"patients",
"solid tumors",
"carcinoma",
"sorafenib",
"growth factor",
"therapy",
"weeks",
"efficacy",
"version 4.0",
"predictors",
"progression",
"days",
"survival",
"treatment",
"group",
"initiation",
"BackgroundSorafenib",
"ConclusionsHypertension",
"tumors",
"worsening",
"months",
"duration bias",
"criteria",
"onset",
"study",
"rate",
"evaluation criteria",
"agents",
"factors",
"development",
"occurrence",
"time",
"analysis",
"bias",
"images",
"order"
],
"name": "Development of hypertension within 2 weeks of initiation of sorafenib for advanced hepatocellular carcinoma is a predictor of efficacy",
"pagination": "105-110",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1051226834"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/s10147-014-0691-5"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"24744262"
]
}
],
"sameAs": [
"https://doi.org/10.1007/s10147-014-0691-5",
"https://app.dimensions.ai/details/publication/pub.1051226834"
],
"sdDataset": "articles",
"sdDatePublished": "2022-08-04T17:02",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_635.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1007/s10147-014-0691-5"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10147-014-0691-5'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10147-014-0691-5'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10147-014-0691-5'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10147-014-0691-5'
This table displays all metadata directly associated to this object as RDF triples.
317 TRIPLES
21 PREDICATES
109 URIs
96 LITERALS
22 BLANK NODES